artificial intelligence
Claude's Role in Capturing Nicolás Maduro
HeadlinesOn February 13, the Wall Street Journal reported something that hadn't been public before: the Pentagon used Anthropic's Claude AI during the January raid that...
Claude vs Open AI: Real Fight Is Business Model
TL;DR Last week OpenAI announced ads in ChatGPT's free tier. Within hours, Claude launched a "No Ads, Ever" campaign. Twitter turned into a roast session....
Google DeepMind is worried about what happens when millions of agents start to interact
Google DeepMind is funding research into the potential dangers of situations where millions of different AI agents interact with each other online. According to Rohin Shah,...
Job titles of the future: Nature’s drug designer
In 2018, after nearly two decades working in Big Pharma, chemist Tim Cernak was ready to put his skills to a new use. For Merck,...
Inside soccer’s data renaissance
Imagine tuning in to the opening kickoff of a World Cup match and seeing a player intentionally send the ball all the way down the...
Why China is betting on big nuclear reactors
It’s a tale of two nuclear industries. In China, large reactors are coming together at a stunning pace. The country has nearly doubled its nuclear...
The Download: the “steroid olympics” and a safer Mythos
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. The...
The “steroid olympics” were a circus—and a window into our culture
Testosterone. Methenolone. Nandrolone. Human growth hormone and EPO. Meldonium, modafinil, and mixed amphetamine salts. Clomiphene, anastrozole, levothyroxine, and liothyronine. Patches and capsules, creams and pills....
The Download: whole-body rejuvenation drugs and five things to know about AI
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. David...
Learning to lead in a hybrid human-AI enterprise
As adoption of AI agents looks set to surge by as much as 300% in the next two years, leadership teams are carefully considering the implications...
David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a prescription that will make you...
Five things you need to know about AI
At SXSW London last week I gave a talk called “Five things you need to know about AI,” in which I shared what I think...